argenx SE | ARGX - Current Liabilities

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
656.38

argenx SE reported $1.32B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AstraZeneca USD 32.57B 1.95B Mar/2026
Genmab DKK 1.43B 686M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
GRIFOLS EUR 2.12B 105M Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lakefront Biotherapeutics EUR 100.42M 52.44M Mar/2026
Qiagen NV USD 512.14M 461.26M Dec/2025
UCB EUR 4.4B 470M Dec/2025